Lyka Labs Limited (BOM:500259)
India · Delayed Price · Currency is INR 58.35
-0.70 (-1.19%)
At close: Apr 22, 2026
Lyka Labs Market Cap
Lyka Labs has a market cap or net worth of 2.12 billion as of April 22, 2026. Its market cap has decreased by -40.49% in one year.
Market Cap
2.12B
Enterprise Value
2.43B
Revenue
1.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
58.35
Market Cap Chart
Since October 1, 2003, Lyka Labs's market cap has increased from 294.62M to 2.12B, an increase of 620.65%. That is a compound annual growth rate of 9.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 2.11B | -22.18% |
| Dec 31, 2025 | 2.71B | -51.91% |
| Dec 31, 2024 | 5.63B | 37.55% |
| Dec 29, 2023 | 4.09B | 10.05% |
| Dec 30, 2022 | 3.72B | -41.66% |
| Dec 31, 2021 | 6.38B | 617.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trident Lifeline | 2.94B |
| Everest Organics | 2.73B |
| Gennex Laboratories | 2.59B |
| Speciality Medicines | 2.50B |
| Ambalal Sarabhai Enterprises | 2.47B |
| BDH Industries | 2.17B |
| Sanjivani Paranteral | 2.16B |
| Oxygenta Pharmaceutical | 2.08B |